EUVIMEDEUVIMED entdecken
Crossref

77042 “Augmented” High-Dose Infliximab 12.5 mg/kg is Safe and Effective in Hidradenitis Suppurativa

Isabell A. Guzchenko, Alexis Mitelman, Huongly K. Do, Sarah Romanelli, Isabel M. Trenholm, Isabella J. Tan, Steven R. Cohen

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB8

DOI: 10.1016/j.jaad.2026.04.048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Isabell A. Guzchenko und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Guzchenko, I. A., Mitelman, A., Do, H. K., Romanelli, S., Trenholm, I. M., Tan, I. J., & Cohen, S. R. (2026). 77042 “Augmented” High-Dose Infliximab 12.5 mg/kg is Safe and Effective in Hidradenitis Suppurativa. Journal of the American Academy of Dermatology, 95(1), AB8. https://doi.org/10.1016/j.jaad.2026.04.048

Vancouver

Guzchenko IA, Mitelman A, Do HK, Romanelli S, Trenholm IM, Tan IJ, et al. 77042 “Augmented” High-Dose Infliximab 12.5 mg/kg is Safe and Effective in Hidradenitis Suppurativa. Journal of the American Academy of Dermatology. 2026;95(1):AB8. doi:10.1016/j.jaad.2026.04.048

BibTeX
@article{Guzchenko2026,
  author = {Guzchenko, Isabell A. and Mitelman, Alexis and Do, Huongly K. and Romanelli, Sarah and Trenholm, Isabel M. and Tan, Isabella J. and Cohen, Steven R.},
  title = {77042 “Augmented” High-Dose Infliximab 12.5 mg/kg is Safe and Effective in Hidradenitis Suppurativa},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB8},
  doi = {10.1016/j.jaad.2026.04.048}
}
Kostenlos starten →